http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112646036-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112646036-B |
titleOfInvention | anti-CD 23 specific monoclonal antibody and application thereof |
abstract | The invention relates to an anti-CD 23 specific monoclonal antibody, wherein the amino acid sequence of the heavy chain variable region is as shown in SEQ ID No: 6, and the amino acid sequence of the light chain variable region is shown as SEQ ID No: 7. The anti-CD 23 specific monoclonal antibody has the nucleotide sequence of the heavy chain variable region of the anti-CD 23 specific monoclonal antibody as shown in SEQ ID No: 4, the nucleotide sequence of the light chain variable region of the monoclonal antibody for encoding the anti-CD 23 specificity is shown as SEQ ID No: 5, respectively. The anti-CD 23 specific monoclonal antibody can accurately identify CD23 molecules in a lymphohematopoietic system, and shows positive high expression in diseases such as chronic lymphocytic leukemia, mediastinal large B cell lymphoma, systemic lupus erythematosus and the like. Therefore, the anti-CD 23 specific monoclonal antibody of the invention can be used for accurately diagnosing various lymphohematopoietic diseases so as to improve the accuracy of diagnosis and detection. |
priorityDate | 2021-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 420.